CEP-40783
Cat. No.:YN440025
产品名称: | CEP-40783 |
CAS No.: | 1437321-24-8 |
Chemical Name: | N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-5-pyrimidinecarboxamide |
Synonyms: | RXDX-106 |
分子量: | 588.56 |
分子式: | C₃₁H₂₆F₂N₄O₆ |
SMILES: | O=C(C1=CN(C(C)C)C(N(C2=CC=C(F)C=C2)C1=O)=O)NC3=CC=C(OC4=CC=NC5=CC(OC)=C(OC)C=C45)C(F)=C3 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | CEP-40783是高效选择性,有口服活性的AXL和c-Met抑制剂,IC50值分别为7 nM 和12 nM。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Miknyoczki, S.J., Cheng, M., Hudkins, R., et al.CEP-40783: A potent and selective AXL/c-Met inhibitor for use in breast, non-small cell lung (NSCLC), and pancreatic cancersMol. Cancer Ther.12(11 Suppl),C275(2013)
Yokoyama, Y., Lew, E.D., Seelige, R., et al.Immuno-oncological efficacy of RXDX-106, a novel TAM (TYRO3, AXL, MER) family small-molecule kinase inhibitorCancer Res.79(8),1996-2008(2019)